Sachin Narayan is a current medical student at the Stanford University School of Medicine. He previously worked as a researcher and lead of the undergraduate research program at the University of Southern California (USC) Michelson Convergent Science Institute in Cancer. Since joining USC’s Convergent Science Institute in Cancer in the fall of 2018, Sachin primarily focused on the liquid biopsy of colorectal cancer patients and patients receiving CAR T-cell immunotherapy. Apart from research, he is also the founder and CEO of Cathartic, a social enterprise dedicated to alleviating preventative health inequities for under-resourced groups by improving their access to health and hygiene products. Sachin is a Trustee Scholar at USC and received a full-tuition merit scholarship for his undergraduate education.